Literature DB >> 11295073

The complementary role of beta-catenin in diagnosing various subtypes of renal cell carcinomas and its up-regulation in conventional renal cell carcinomas with high nuclear grades.

L Guo1, N Kuroda, E Miyazaki, Y Hayashi, M Toi, K Naruse, M Hiroi, S Ashida, T Shuin, H Enzan.   

Abstract

beta-catenin is a kind of cytoplasmic protein involved in cell adhesion and signal transduction. This study investigated its expression in various subtypes of renal cell carcinomas (RCCs) using an immunohistochemical staining method. beta-catenin expression was assessed from staining frequency and staining score. Staining score was performed by evaluating both staining percentage and intensity. All subtypes of RCCs reacted positively with beta-catenin. However, the positive frequency and staining score in papillary and chromophobe RCCs were significantly higher than those in conventional RCCs (p < 0.05). In addition, in conventional RCCs, the positive frequency and staining score of beta-catenin showed a significant difference between nuclear grades I/II and grade III (p < 0.05). Therefore, it may indicate that beta-catenin can serve as a complementary tool to distinguish conventional RCCs from chromophobe RCCs. In conventional RCCs with low nuclear grades, beta-catenin expression is generally down-regulated, while it appears to be preserved in those with high nuclear grades.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295073     DOI: 10.3892/or.8.3.521

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  4 in total

1.  Integrin-linked kinase (ILK) expression correlates with tumor severity in clear cell renal carcinoma.

Authors:  Míriam de Fátima Brasil Engelman; Rogério Mendes Grande; Marcelo Andery Naves; Marcello Fabiano de Franco; Vicente de Paulo Castro Teixeira
Journal:  Pathol Oncol Res       Date:  2012-07-20       Impact factor: 3.201

2.  Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma.

Authors:  Hanna Ronkainen; Saila Kauppila; Pasi Hirvikoski; Markku H Vaarala
Journal:  J Exp Clin Cancer Res       Date:  2010-01-14

3.  α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas.

Authors:  Sarit Aviel-Ronen; Oranit Zadok; Aya Vituri; Dvora Nass; Ignat Schwartz; Camila Avivi; Iris Barshack
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

4.  Immunohistochemical analysis of beta-catenin expression: a probable prognostic marker and potential therapeutic target in renal cell carcinoma.

Authors:  Ayan Kundu; Anway Sen; Shouvik Choudhury; Tapan Kumar Mandal; Debasish Guha; Sandeep Lahiry
Journal:  Med Pharm Rep       Date:  2021-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.